PUBLISHER: Orion Market Research | PRODUCT CODE: 1064641
PUBLISHER: Orion Market Research | PRODUCT CODE: 1064641
Global Acral Lentiginous Melanoma Drugs Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Immuno Therapy, and Targeted Therapy), Forecast Period (2021-2027)
The global acral lentiginous melanoma drugs market is anticipated to grow at a considerable CAGR during the forecast period. Melanoma that develops on the palms or soles is known as acral lentiginous melanoma. Acral lentiginous melanoma begins as a flat area of discolored skin that progressively grows in size. According to the National Center for Biotechnology Information, acute lentiginous melanoma accounts for around 2%-3% of all melanomas
The global acral lentiginous melanoma drugs market is segmented based on therapy into chemotherapy, targeted therapy, and immune therapy. Geographically, the global acral lentiginous melanoma drugs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.
Market Segmentation
The Report Covers